Year: 2020

EVLI BANK PLC STOCK EXCHANGE RELEASE/INSIDE INFORMATION DECEMBER 28, 2020, 5.00 PM. (EET/EEST)During the last quarter of the year the business has developed well. In addition, the general equity and fixed income markets have developed favorably. As a result, the company is specifying its outlook for 2020.Because of the positive development, we estimate our operating profit for 2020 to be above the level of the comparison period.Earlier we estimated that our operating profit for 2020 will be clearly positive. Evli Bank Plc´s Financial Statement Bulletin for 2020 will be released on Friday January 22, 2021.EVLI BANK PLCFor further information:Maunu Lehtimäki, CEO, Evli Bank Plc, tel. +358 (0)50 553 3000, maunu.lehtimaki@evli.comJuho Mikola, CFO, Evli Bank Plc, tel. +358 (0)40 717 8888, juho.mikola@evli.comEvli Bank PlcEvli is a bank specialized...

EVLI PANKKI OYJ:N PÖRSSITIEDOTE/SISÄPIIRITIETO 28.12.2020 KLO 17.00 (EET/EEST)Vuoden viimeinen neljännes on sujunut liiketoiminnallisesti hyvin. Lisäksi yleinen osake- ja korkomarkkinoiden kehitys on ollut suotuisaa. Tämän takia yhtiö tarkentaa näkymiään vuodelle 2020.Positiivisen kehityksen seurauksena arviomme vuoden 2020 liikevoiton ylittävän vertailukauden tason.Aiemmin arvioimme vuoden 2020 liikevoiton olevan selvästi positiivinen.Evli Pankin tilinpäätöstiedote vuodelta 2020 julkaistaan perjantaina 22.1.2021.EVLI PANKKI OYJLisätietoja: Maunu Lehtimäki, toimitusjohtaja, Evli Pankki Oyj, p. +358 (0)50 553 3000, maunu.lehtimaki@evli.comJuho Mikola, talousjohtaja, Evli Pankki Oyj, p. +358 (0)40 717 8888, juho.mikola@evli.comEvli Pankki OyjEvli on sijoittamiseen erikoistunut pankki, joka auttaa yhteisöjä, yrityksiä ja yksityishenkilöitä...

These Product Offerings Include CBD Infused: Face Moisturizer, Anti-Wrinkle Cream, Collagen/Tightening/Detoxifying Face Masks, Lip Balm, Hand & Foot Cream, Transdermal Patch, Massage & Body Oil, Body Spray, and Roll-On Product  NEW YORK, NY, Dec. 28, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnologies initiatives, today announced that its recently launched Skin Care Offerings have now been expanded to include more than 10 distinct CBD Infused products.  These product offerings include CBD Infused: Face Moisturizer (100mg),...

AS Ekspress Grupp informs about the change in the structure of shareholders with substantial holdings.On 28.12.2020, OÜ HHL Rühm informed AS Ekspress Grupp that as a result of recent transactions, Hans Luik’s indirect holding in AS Ekspress Grupp will increase to a total of 60.28%. During the period from 22nd December to 28th December 2020, OÜ HHL Rühm has acquired 1,096,475 shares of Ekspress Grupp.OÜ HHL Rühm owns 34.42% (10,599,525 shares) and Hans Luik owns 25.86% (7,963,307 shares) of the shares of AS Ekspress Grupp after the transaction on 28 December 2020.Signe KukinGroup CFOAS Ekspress Grupp +372 669 8381signe.kukin@egrupp.eeAS Ekspress Grupp is the leading media group in the Baltic States whose key activities include web media content production, publishing of newspapers and magazines and provision of printing services in Estonia,...

AS Ekspress Grupp teatab muudatusest olulist osalust omavate aktsionäride struktuuris.28.12.2020 informeeris OÜ HHL Rühm ASi Ekspress Grupp, et hiljutiste tehingute tulemusel tõuseb Hans Luige kaudne osalus ASis Ekspress Grupp kokku 60,28%ni. Perioodil 22.-28. detsembrini 2020 on OÜ HHL Rühm omandanud 1 096 475 Ekspress Grupi aktsiat.Peale 28.12.2020 toimunud tehingut kuulub OÜ-le HHL Rühm 34,42% (10 599 525 aktsiat) ja Hans Luigele 25,86% (7 963 307 aktsiat) ASi Ekspress Grupp aktsiatest.Signe KukinKontserni finantsjuhtAS Ekspress Grupp+372 669 8381signe.kukin@egrupp.eeAS Ekspress Grupp on Baltimaade juhtiv meediakontsern, mille tegevus hõlmab veebimeedia sisutootmist, ajalehtede ja ajakirjade kirjastamist ning trükiteenuste osutamist Eestis, Lätis ja Leedus. Samuti haldab kontsern elektroonilist piletimüügiplatvormi ja piletimüügikohti...

Boca Raton, Florida, Dec. 28, 2020 (GLOBE NEWSWIRE) — Simplicity Esports and Gaming Company (OTCQB:WINR) (“Simplicity Esports”), announced that it has signed a consulting agreement that will generate approximately $250,000 in revenue for planning, designing, and buildout of an esports gaming center at 3130 N Downer Ave in Milwaukee, WI. The owners of the commercial building, directly across the street from University of Wisconsin-Milwaukee contacted Simplicity Esports to leverage the experience of the company with the largest footprint of esports gaming centers in North America, to assist them in the planning and development of their esports gaming center. The gaming center is expected to open to the public during the first calendar quarter of 2021.Roman Franklin, President of Simplicity Esports, stated, “We expect that this is...

PROGRAMME DE RACHATDECLARATION DES TRANSACTIONS SUR ACTIONS PROPRESSOCIETE FLEURY MICHONPrésentation agrégée par jour et par marchéPériode : 21/12/2020 au 24/12/2020Détail transaction par transactionPièce jointeDéclaration Transactions du 21 au 24 décembre 2020

Acquisition Would Signify a Strategic Investment into the Recirculating Aquaculture Systems (RAS) IndustryMiami, Florida, Dec. 28, 2020 (GLOBE NEWSWIRE) — Blue Star Foods Corp., (OTC: BSFC) (“Blue Star”), a sustainable seafood company, announced today that it has signed a term sheet to acquire Taste of BC Aquafarms, Inc. (“Taste of BC Aquafarms”), a family-owned and operated land-based Recirculating Aquaculture Systems (RAS) salmon farming operation, based in Nanaimo, British Columbia, Canada, subject to certain closing conditions.“We believe land-based salmon farming can be part of the solution of healing our environment and will meet the gap between the growing global demand of salmon and a supply that is limited by its environmental impact, as well as geographical and governmental constraints,” said the Company’s Chairman and...

PREVENT-19 will assess the efficacy, safety and immunogenicity of NVX-CoV2373 in the prevention of COVID-19Trial to enroll up to 30,000 volunteers across approximately 115 sites in the U.S. and MexicoTwo-thirds of enrollees to receive active vaccineGAITHERSBURG, Md., Dec. 28, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced initiation of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of NVX-CoV2373, the Company’s COVID-19 vaccine candidate. The trial builds on research from Phase 1/2 studies demonstrating that the vaccine provoked a robust immune response, generated highly neutralizing antibodies against the virus and was generally...

Under henvisning til lov om investeringsforeninger m.v. § 75, stk. 1, samt NASDAQ Copenhagen A/S´ regler for udstedere af UCITS-andele skal ID- Sparinvest, Filial af Sparinvest S.A., Luxembourg på vegne af Investeringsforeningen Sparinvest meddele, at den offentliggjorte indre værdi på nedenstående afdelinger har været forkert fastsat ved prisudsendelse i perioden fra den 23 december 2020. kl. 09:45 frem til kl. 12:21 samme dag.Indre værdi har været forkert beregnet for følgende afdelinger:                                             Der har ikke været emissioner eller indløsninger i afdelingerne i perioden for fejlberegningen.Proceduren om meddelelse om fejlberegningen til Børsmæglerforeningens medlemmer er igangsat. Henvendelser vedrørende nærværende fondsbørsmeddelelse kan rettes til ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg,...